Search Results - "Blumberg, E"

Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic by Goldberg, D. S., Blumberg, E., McCauley, M., Abt, P., Levine, M.

“…Death rates from drug overdoses have nearly doubled since 2003, with over 47 000 deaths in 2014. This is largely attributable to the opioid epidemic. If the…”
Get full text

Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management by Huprikar, S., Danziger‐Isakov, L., Ahn, J., Naugler, S., Blumberg, E., Avery, R. K., Koval, C., Lease, E. D., Pillai, A., Doucette, K. E., Levitsky, J., Morris, M. I., Lu, K., McDermott, J. K., Mone, T., Orlowski, J. P., Dadhania, D. M., Abbott, K., Horslen, S., Laskin, B. L., Mougdil, A., Venkat, V. L., Korenblat, K., Kumar, V., Grossi, P., Bloom, R. D., Brown, K., Kotton, C. N., Kumar, D.

“…Use of organs from donors testing positive for hepatitis B virus (HBV) may safely expand the donor pool. The American Society of Transplantation convened a…”
Get full text

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients by Humar, A., Lebranchu, Y., Vincenti, F., Blumberg, E. A., Punch, J. D., Limaye, A. P., Abramowicz, D., Jardine, A. G., Voulgari, A. T., Ives, J., Hauser, I. A., Peeters, P.

“…Late‐onset cytomegalovirus (CMV) disease is a significant problem with a standard 3‐month prophylaxis regimen. This multicentre, double‐blind, randomized…”
Get full text

Donor‐Derived Disease Transmission Events in the United States: Data Reviewed by the OPTN/UNOS Disease Transmission Advisory Committee by Ison, M. G., Hager, J., Blumberg, E., Burdick, J., Carney, K., Cutler, J., DiMaio, J. M., Hasz, R., Kuehnert, M. J., Ortiz‐Rios, E., Teperman, L., Nalesnik, M.

“…Donor‐derived disease transmission is increasingly recognized as a source of morbidity and mortality among transplant recipients. Policy 4.7 of the Organ…”
Get full text

Zika Virus in Transplantation: Emerging Infection and Opportunities by Blumberg, E. A., Fishman, J. A.

“…Assay development for organ donor screening and clinical diagnosis should be accelerated with research to define the behavior of Zika in transplantable organs…”
Get full text

Human Immunodeficiency Virus in Solid Organ Transplantation by Blumberg, E. A., Rogers, C. C.

Get full text

2016 Influenza Vaccine Recommendations: A Summary of the MMWR Report by Blumberg, E. A.

“…This report summarizes the recommendations for this year's influenza vaccine administration…”
Get full text

Coccidioidomycosis Transmission Through Organ Transplantation: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee by Kusne, S., Taranto, S., Covington, S., Kaul, D. R., Blumberg, E. A., Wolfe, C., Green, M.

“…Donor‐derived coccidioidomycosis has caused unexpected morbidity and mortality in transplant recipients. All proven or probable reports of donor‐derived…”
Get full text

Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis by Stevens, D.R., Sawinski, D., Blumberg, E., Galanakis, N., Bloom, R.D., Trofe-Clark, J.

“…Objective We compared the effectiveness of lower‐dose (LD) (450 mg/day for 6 months) to standard‐dose (SD) (900 mg/day for 6 months) valganciclovir (VGCV)…”
Get full text

Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations by Kumar, D., Blumberg, E. A., Danziger‐Isakov, L., Kotton, C. N., Halasa, N. B., Ison, M. G., Avery, R. K., Green, M., Allen, U. D., Edwards, K. M., Miller, G., Michaels, M. G.

“…Influenza virus causes a spectrum of illness in transplant recipients with a high rate of lower respiratory disease. Seasonal influenza vaccination is an…”
Get full text

It's not too late: a proposal to standardize the terminology of "late-onset" cytomegalovirus infection and disease in solid organ transplant recipients by Razonable, R.R., Blumberg, E.A.

Get full text

Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening by Suryaprasad, A., Basavaraju, S. V., Hocevar, S. N., Theodoropoulos, N., Zuckerman, R. A., Hayden, T., Forbi, J. C., Pegues, D., Levine, M., Martin, S. I., Kuehnert, M. J., Blumberg, E. A.

“…Nucleic acid testing (NAT) for hepatitis C virus (HCV) is recommended for screening of organ donors, yet not all donor infections may be detected. We describe…”
Get full text

HIV‐Infected Liver and Kidney Transplant Recipients: 1‐ and 3‐Year Outcomes by Roland, M. E., Barin, B., Carlson, L., Frassetto, L. A., Terrault, N. A., Hirose, R., Freise, C. E., Benet, L. Z., Ascher, N. L., Roberts, J. P., Murphy, B., Keller, M. J., Olthoff, K. M., Blumberg, E. A., Brayman, K. L., Bartlett, S. T., Davis, C. E., McCune, J. M., Bredt, B. M., Stablein, D. M., Stock, P. G.

“…Improvements in human immunodeficiency virus (HIV)‐associated mortality make it difficult to deny transplantation based upon futility. Outcomes in the current…”
Get full text

Considerations for Screening Live Kidney Donors for Endemic Infections: A Viewpoint on the UNOS Policy by Levi, M. E., Kumar, D., Green, M., Ison, M. G., Kaul, D., Michaels, M. G., Morris, M. I., Schwartz, B. S., Echenique, I. A., Blumberg, E. A.

“…In February 2013, the Organ Procurement and Transplantation Network mandated that transplant centers perform screening of living kidney donors prior to…”
Get full text

Just Say No: Stemming the Tide of Antibiotic Overprescription by Blumberg, E. A.

“…Treatment of asymptomatic bacteriuria following kidney transplant is probably not warranted given recent research presented in this issue. See page 2943 for…”
Get full text

MMWR: Surveillance for Violent Deaths–National Violent Death Reporting System, 16 States, 2010 by Blumberg, E. A.

“…This month's MMWR report is a summary of US surveillance data related to victims of violent death, an important contributor to the deceased donor population…”
Get full text

Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis by Longworth, S.A., Blumberg, E.A., Barton, T.D., Vinnard, C.

“…The relationship of non-tuberculous mycobacterial (NTM) infections and survival among solid organ transplant recipients is unknown. We conducted a…”
Get full text

MMWR: CDC Guidance for Evaluating Healthcare Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management by Blumberg, E. A.

“…This article summarizes recent recommendations of the CDC regarding prevention of hepatitis B in healthcare personnel…”
Get full text

Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study by Longworth, S.A., Vinnard, C., Lee, I., Sims, K.D., Barton, T.D., Blumberg, E.A.

“…Background The epidemiology of nontuberculous mycobacteria (NTM) disease in solid organ transplant recipients is poorly defined. Methods We identified all…”
Get full text

Cytomegalovirus‐Responsive CD8+ T Cells Expand After Solid Organ Transplantation in the Absence of CMV Disease by Higdon, L. E., Trofe‐Clark, J., Liu, S., Margulies, K. B., Sahoo, M. K., Blumberg, E., Pinsky, B. A., Maltzman, J. S.

“…Cytomegalovirus (CMV) is a major cause of morbidity and mortality in solid organ transplant recipients. Approximately 60% of adults are CMV seropositive,…”
Get full text